Your report explained
What is pathological complete response (pCR)?
A pathological complete response means that when the tissue removed at your operation was examined under a microscope, no invasive cancer was found in the breast or the lymph nodes. It is the result the whole approach aims for. This page explains how much it tells you, how that differs by subtype, and why treatment continues.
On this page
- What does pathological complete response mean?
- The wording, in plain language
- How much a complete response tells you, by subtype
- Two results that sound the same and are not
- What a complete response cannot tell you
- What families conclude from this result
- What still continues, and for how long
- Common questions about complete response
The short answer
What does pathological complete response mean?
It means that when the tissue removed at your operation was examined under a microscope, no invasive cancer was found in the breast or in the lymph nodes. The chemotherapy given before surgery cleared what was visible and what was microscopic. It is written on reports as pCR.
Why it is such a good result
It tells you that your cancer was highly sensitive to the treatment it received. Across many studies, women who achieve it, particularly with triple negative and HER2 positive cancers, have gone on to do better than those with cancer remaining. It is the outcome the whole approach aims for.
What it is not
It is not a promise. It describes what was found in the tissue that was removed, and it cannot see cells that may be elsewhere in the body. This is why radiotherapy and hormone tablets continue as planned afterwards.
On your report
The wording, in plain language
- pCR, or pathological complete response
- No invasive cancer found in the breast or the nodes at surgery.
- ypT0 ypN0
- The staging shorthand for the same thing. The y means the staging follows treatment given before surgery.
- ypTis
- No invasive cancer, but DCIS still present. This still counts as a complete response under the definition most centres use.
- Clinical complete response
- Nothing could be felt or seen on a scan before surgery. It is not the same thing, and it is much less reliable.
- Residual disease
- Cancer still present at surgery. The opposite result, and the one that leads to additional treatment.
- DCIS
- Cancer cells still held inside the milk ducts, which have not invaded surrounding tissue.
Not sure whether this applies to you?
Ask an oncologistIt means different things
How much a complete response tells you, by subtype
The same result carries very different weight depending on what kind of breast cancer you have.
Triple negative
This is where it matters most. Achieving it is strongly reassuring, and not achieving it is the trigger for additional treatment after surgery.
HER2 positive
Complete responses are common with modern HER2 treatment, and are a good sign. Where cancer remains, the treatment given afterwards is usually changed because of it.
Ask what is planned for you either way.Hormone sensitive, HER2 negative
Complete responses are uncommon here, and their absence is not alarming. These cancers respond slowly to chemotherapy, and the long work is done by hormone tablets over years.
What it changes practically
Mostly what is added after surgery. It does not usually change whether you need radiotherapy, which is decided on what the cancer was at the start.
Usually unchanged by pCR
- Radiotherapy
- Hormone tablets, if you are receptor positive
- The follow-up schedule
Side by side
Two results that sound the same and are not
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Being straight with you
What a complete response cannot tell you
It cannot tell you that the cancer will never return. A small number of women who achieve it do have a recurrence later, because the result describes the tissue that was removed and not every cell in the body.
Why treatment continues afterwards
Radiotherapy is planned on what the cancer was at the start, not on how well it responded. Hormone tablets continue for years if your cancer is receptor positive. Stopping these on the strength of a good result is the one mistake that could undo the advantage it represents.
It does not change your original stage
Your stage at diagnosis stays on the record, and follow-up is planned around it. Women sometimes assume a complete response resets them to stage zero. It does not, and knowing that avoids confusion later when a new doctor reads the file.
What to do with the result
Take the good news, and then ask two practical questions. What treatment continues from here, and for how long. Write the answers down, because this is the point at which people stop attending appointments and start missing tablets.
Commonly believed
What families conclude from this result
Radiotherapy and hormone tablets usually continue exactly as planned. The complete response tells you the cancer was sensitive to what was given. Finishing the rest of the plan is what preserves that advantage.
It substantially lowers the risk and it is the best result available, but a small number of women do have a recurrence later. Honest follow-up continues for years, and knowing what symptoms to report still matters.
Under the definition most centres use, a complete response means no invasive cancer. DCIS may remain and the result still counts. Your surgeon will still want it removed with a clear margin, which is a separate matter.
Not necessarily. In hormone sensitive cancers a complete response is uncommon and its absence means very little, because those cancers are controlled by tablets over years rather than cleared by chemotherapy. Comparing across subtypes is not meaningful.
After the result
What still continues, and for how long
-
Healing from surgery
A few weeks before anything else begins. Tell your team about any wound problem rather than waiting, because a delay here pushes everything that follows back.
-
Radiotherapy, in most cases
Planned on what the cancer was at diagnosis and on the operation you had, not on how well it responded. A complete response does not usually remove the need for it.
-
HER2 treatment, if it applies
Where your cancer was HER2 positive, targeted treatment generally continues to complete a full year from when it started. Ask for the finish date in writing.
-
Hormone tablets, if you are receptor positive
These run for years and do the long-term work. This is the part that most often lapses once people feel well, and the part where stopping early measurably raises risk.
-
Follow-up appointments
Planned around your stage at diagnosis rather than your response. Ask for the schedule, who to telephone between visits, and how quickly you can be seen if something changes.
Questions we are asked
Common questions about complete response
Am I cancer free?
No invasive cancer was found in the tissue removed, which is the best result this test can give. It is not the same as a promise that no cell survives anywhere, which is why the rest of your treatment continues. Most oncologists will say the result is excellent and still ask you to finish the plan.
Do I still need radiotherapy?
Usually yes. Radiotherapy is decided on what the cancer was at diagnosis and on the operation you had, not on how well it responded. Your radiation oncologist will explain which areas are being treated and why.
Can I stop my hormone tablets?
No. If your cancer was receptor positive, the tablets continue for years and they are doing the long-term work. Stopping early is one of the few decisions that measurably raises the risk of recurrence. If side effects are the problem, say so, because the tablet can usually be changed.
Does this mean I needed less surgery?
The surgery is what produced the result, so it could not have been skipped. Shrinkage often does allow a smaller operation than was first planned, and for many women that is the practical benefit of having chemotherapy first.
How common is it?
It varies enormously by subtype. It is reasonably common in HER2 positive and triple negative cancers treated with modern regimens, and uncommon in hormone sensitive, HER2 negative disease. Ask your oncologist what was realistic for your own subtype.
Will my follow-up be shorter?
Generally not. Follow-up is planned around your stage at diagnosis and the treatment you had. You may feel less anxious at appointments, which is a real benefit, but the schedule itself usually stays the same.
Does it change my risk of it appearing in the other breast?
Not directly. That risk is driven by your inherited risk and your hormone status, and hormone tablets reduce it where they apply. Your other breast continues to be screened yearly, and that should not lapse.
Should I ask for the result in writing?
Yes, and keep it with your pathology report. It is a result you will be asked about by every doctor you see for years, including if you move city or change hospital. Having the wording itself saves a great deal of confusion later.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Sources
- Cancer Research UK — Chemotherapy before surgery for breast cancer
- National Cancer Institute — Pathologic complete response
- Breast Cancer Now — Chemotherapy before surgery
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.